Meril Life Sciences gets 5 years exemption from NPPA for its MeRes100 stent Medical Dialogues Bureau1 March 2020 11:00 AM ISTNew Delhi: The national pharmaceutical regulator NPPA has exempted a new coronary stent developed by Meril Life Sciences from price control for five...